The UFC announced Friday that Felipe Oliveiri is under scrutiny for a potential anti-doping policy violation. The Brazilian, who lost to Tony Martin via submission in his promotional debut on Jan. 30, tested clean for prohibited substances on fight night, but an out-of-competition test came with a different result.
The UFC’s statement can be read below.
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Felipe Olivieri of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection. Although the sample collected from Olivieri following his bout at UFC Fight Night: Johnson vs. Bader on January 30, 2016, was reported as negative for prohibited substances, a sample collected from him in Brazil earlier that month, and analyzed at the WADA accredited laboratory in Rio de Janeiro, was recently reported to USADA as containing a prohibited substance.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Olivieri, as it relates to the UFC Anti-Doping Policy and future UFC participation. Because Olivieri participated in a bout sanctioned by the New Jersey State Athletic Control Board after the sample in question was collected, USADA will work to ensure that the Board has the necessary information to determine the appropriate course of action under the Board’s rules.
Olivieri, 29, signed with the UFC after racking up a 14-4-0-1 record fighting in promotions like Shooto Brazil and Pancrase. The Nova Uniao fighter was competing for the fourth time outside of Brazil when he faced Martin in Newark.
Update: Oliveiri told MMAFighting.com he never used any illegal substance, and will ask for the B-sample to be tested. The UFC and USADA did not announce which substance Olivieri was flagged for, but Nova Uniao head coach Andre Pederneiras told MMAFighting.com it was methyltestosterone.